It’s been developed by Elysium Health, a research company that merges Silicon Valley’s infatuation with living forever with East Coast science.
The development of the pill to be sold online should not work us up too much, but there’s a little detail: Elysium boasts five Nobel Prize winners (two for chemistry, three for medicine) in an advisory role. That’s interesting in two ways. The first is that Basis will be labelled a “dietary supplement,” as Elysium hasn’t yet tested the substance on humans, something necessary to sell it as an FDA-approved drug
For its part, Elysium has promised to conduct human tests as soon as possible, and to release the results to the public– although it may take decades to get conclusive evidence. Even after that, Basis could still have a hard time to get the FDA’s stamp of approval, as the authority does not recognize old age as a disease in itself.